CHINA MEDICAL UNIVERSITY HOSPITAL
🇹🇼Taiwan
The Effect of Lactobacillus Delbrueckii Subsp. Bulgaricus on Human's Weight Reduction
Not Applicable
Completed
- Conditions
- Overweight and Obesity
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Probiotics
- First Posted Date
- 2024-02-06
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 36
- Registration Number
- NCT06244186
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease
Phase 3
Not yet recruiting
- Conditions
- COVID-19Influenza Viral Infections
- Interventions
- Drug: Placebo control drugDrug: Formosa 1-Breath Free (NRICM101)
- First Posted Date
- 2023-12-19
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 170
- Registration Number
- NCT06175468
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
The Effect of a Multi-intervention Program and Protein Food Sources on Preventing and Mitigating Sarcopenia
Not Applicable
Completed
- Conditions
- SarcopeniaDietary ExposureNutrition, HealthyBone HealthMuscle FunctionMuscle Performance
- Interventions
- Dietary Supplement: multi-intervention program and protein foods supplementation
- First Posted Date
- 2023-12-15
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 86
- Registration Number
- NCT06173271
- Locations
- 🇨🇳
Yi-Chen Huang, Taichung, Baseline And Post Test Of Intervention, Taiwan
TCM Constitution, Pattern Types, and Disease Factors in Primary Lung Cancer.
Recruiting
- Conditions
- SyndromeMedicine, Chinese TraditionalRisk FactorsBody Constitution
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-01-02
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 250
- Registration Number
- NCT06143436
- Locations
- 🇨🇳
China Medical University Hospital, Taichung City, Taiwan
Efficacy of Acupuncture in Patients Post-Covid Brain Fog
Not Applicable
Not yet recruiting
- Conditions
- Brain Fog
- Interventions
- Other: Acupuncture
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT06144320
Efficacy of Abdominal Catgut Embedding Combined With Auricular Acupressure Therapy for Obese Patients
Not Applicable
Completed
- Conditions
- Acupuncture
- Interventions
- Other: Catgut Embedding at acupoints
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 44
- Registration Number
- NCT06133205
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Navigation Image Accuracy Test in Cervical Spine Surgery Using Anatase Spine Surgery Navigation System
Not Applicable
Not yet recruiting
- Conditions
- Cervical Spine Fusion
- Interventions
- Device: Anatase Spine Surgery Navigation System
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT06117267
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery
Not Applicable
Recruiting
- Conditions
- Thoracic Neoplasms
- Interventions
- Behavioral: Tai Chi Exercise
- First Posted Date
- 2023-10-27
- Last Posted Date
- 2025-04-24
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06104774
- Locations
- 🇨🇳
China Medical University, Taichung, North Dist., Taiwan
Decoding Risks and Rewards in Ischemic Stroke Surgery
Completed
- Conditions
- Ischemic Stroke
- First Posted Date
- 2023-10-24
- Last Posted Date
- 2023-10-24
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 204411
- Registration Number
- NCT06098066
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients
Phase 1
Recruiting
- Conditions
- Non-small Cell Lung CancerEGFR Gene MutationEGFR-TKI Resistant Mutation
- Interventions
- Drug: Nintedanib, gefitinib, erlotinib, afatinib, osimertinib
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2025-01-23
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06071013
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan